Page last updated: 2024-09-03

u 92032 and Neuroblastoma

u 92032 has been researched along with Neuroblastoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Im, WB; Ito, C; Kunihara, M; Liou, SY; Takagi, H; Takahashi, M; Tsuzuki, K	1

Other Studies

1 other study(ies) available for u 92032 and Neuroblastoma

Article	Year
U-92032, a T-type Ca2+ channel blocker and antioxidant, reduces neuronal ischemic injuries. European journal of pharmacology, 1994, May-23, Volume: 257, Issue:3 Topics: Animals; Antioxidants; Brain Ischemia; Calcium Channel Blockers; Flunarizine; Gerbillinae; Hippocampus; Lipid Peroxidation; Long-Term Potentiation; Malondialdehyde; Mice; Neuroblastoma; Neurons; Piperazines; Rats; Tropolone; Tumor Cells, Cultured	1994

Article

Year

U-92032, a T-type Ca2+ channel blocker and antioxidant, reduces neuronal ischemic injuries.

European journal of pharmacology, 1994, May-23, Volume: 257, Issue:3

Topics: Animals; Antioxidants; Brain Ischemia; Calcium Channel Blockers; Flunarizine; Gerbillinae; Hippocampus; Lipid Peroxidation; Long-Term Potentiation; Malondialdehyde; Mice; Neuroblastoma; Neurons; Piperazines; Rats; Tropolone; Tumor Cells, Cultured

1994